Study for drug absorption from gastrointestinal tract #01: study with 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG)

Study for drug absorption from gastrointestinal tract #01: study with 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) - Oral administration PET #01

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003061

Enrollment

Registered

2010-01-19

Start date

2009-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy male subjects

Interventions

Number of subjects

25 Period of study

2 days 1) Volunteers are fasted overnight. 2) Volunteers are administered a capsule containing [18F]FDG solution, and then PET scan and blood sampling are performed periodically.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) Healthy Japanese men at the age between 18 to 60 years, enable to be taken a PET scan for 90 minutes. 2) Volunteers will be attended by their own accordance and unforced by hierarchical relationships.

Exclusion criteria

Exclusion criteria: The health history of gastroptosis

Design outcomes

Primary

Measure	Time frame
Time-course of drug concentration in the gastrointestinal tract (for 2 hours after oral administration)	—

Secondary

Measure	Time frame
Time-course of drug concentration in the blood (for 2 hours after oral administration)	—

Countries

Japan

Contacts

Public ContactTakashima, Tadayuki

RIKEN Center for Molecular Imaging Science

ttakashima@riken.jp078-304-7124

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026